Gastrointestinal Lymphoma

I. Basics, Histomorphology and Molecular Biology.- Epidemiology and Prognostic Aspects of Gastric Malt-Lymphoma.- Helicobacter pylori in Gastric Mucosa-Associated Lymphoid Tissue Type Lymphoma.- Tumor Biology of Mucosa-Associated Lymphoid Tissue Lymphomas.- Histological Grading with Clinical Relevance in Gastric Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma.- Pathology of Intestinal Lymphomas.- Gastric Mucosa-Associated Lymphoid Tissue Lymphoma: Implications of Animal Models on Pathogenic and Therapeutic Considerations — Mouse Models of Gastric Lymphoma.- II. State-of-the-Art.- Vaccination Against Helicobacter pylori.- III. Clinical Aspects.- Primary Gastric Non-Hodgkin’s Lymphoma: Requirements for Diagnosis and Staging.- Gastric Lymphomas: Aspects of Follow-Up and After-Care.- Positron Emission Tomography for Detection and Staging of Malignant Lymphoma.- IV. Therapy.- Gastrointestinal Lymphomas — The Dutch Experience.- Gastrointestinal Lymphomas: The French Experience of the Groupe D’etude des Lymphomes Digestifs (GELD).- Treatment of Primary Gastric Lymphoma: Experience in the National Cancer Center Hospital, Tokyo.- Primary Gastric Lymphoma: Brief Overview of the Recent Princess Margaret Hospital Experience.- Relapse of Low-Grade Gastric MALT Lymphoma After Helicobacter Pylori Eradication: True Relapse or Persistence? Long-Term Post-Treatment Follow-Up of a Multicenter Trial in the North-East of Italy and Evaluation of the Diagnostic Protocol’s Adequacy.- Eradication of Helicobacter pylori and Stability of Remissions in Low-Grade Gastric B-Cell Lymphomas of the Mucosa-Associated Lymphoid Tissue: Results of an Ongoing Multicenter Trial.- Gastrointestinal Lymphomas: The Würzburg Study Experience.